Imaging the immune response
Y ou can learn a lot from a picture. Case in point, a new report from Kamal Khanna, Jeffrey McNamara, and Leo Lefrançois (University of Connecticut, Farmington, CT) images T cells as they prepare to fi ght infection.
To examine the cell dynamics of an immune response, the researchers used laser scanning microscopy to take 3D snapshots of T cells in the spleen during infection. The authors infected mice with Listeria monocytogenes that expressed a well-studied antigen, ovalbumin. They then examined the animals' spleens at different times, staining for T cells (of the CD8 + T cell subtype) that could recognize and kill cells expressing ovalbumin antigens.
Immune responses can be initiated in the spleen, which is subdivided into compartments containing different kinds of immune cells; upon infection, the authors saw increased movements of T cells between certain compartments. Initiation of the immune response in the spleen appeared to take place within the lymphocyte-containing white pulp, at the border between B cell-rich areas and a T cell-rich area known as PALS. What is so special about this zone that drives the immune response will have to be addressed in future studies.
Later during infection, T cells moved between the white pulp and red blood cell-rich red pulp areas of the spleen via structures called bridging channels. Only once they made it to the red pulp did the T cells have access to the circulation and travel to the rest of the body to fi ght infection.
After infection was resolved, memory T cells (those that had seen the antigen) were found in both the red pulp and B cell areas of the spleen. When animals were challenged with a second infection, memory T cells moved from the B cell area to the PALS and commenced later steps in the response. "For a CD8
+ T cell, it was rather bizarre to find them in the B cell areas," says Lefrançois. "We're still trying to understand the functional signifi cance." T umors that escape from their original site are associated with a poor prognosis for cancer patients. New research by Antoine Karnoub, Robert Weinberg (Whitehead Institute, Cambridge, MA), and colleagues suggests that the ability to escape may be acquired through the tumor's interactions with normal tissues.
A growing tumor is considered by its surrounding normal tissue to be a bit like a wound. As also occurs during the wound response, tumors recruit mesenchymal stem cells (MSCs)-which are meant to help with repair-from the bone marrow. Karnoub et al. hypothesized that these MSCs, rather than being helpful, may instead advance disease. To investigate this idea, they injected human breast cancer cells, either alone or along with human MSCs, into mice and then looked for metastases in the animals' lungs.
When MSCs were mixed with tumors, several cancer cell lines were more metastatic. This behavior was reversible; MSCinduced metastases purifi ed from one animal and then injected without MSCs into new animals were no more metastatic than the original primary tumors. MSCs thus seem to teach cancer cells tricks that are not intrinsic to the cancer itself.
Some of these tricks might be learned from MSC-derived chemokines. The MSCs provided two lines of breast cancer cells with the chemokine CCL5, which caused the tumor cells to become more motile and invasive. MSCs had to contact cancer cells to make CCL5, but it is not known what interactions are important. And not every cancer line stimulated CCL5 production. "I liken it to a key-and-lock situation," says Karnoub. "The cancer has the key, but what lock it fi ts to release CCL5 from MSCs is a mystery."
Karnoub is also interested in how cancer cells cause longterm changes in MSC behavior. "The MSCs remembered having been in contact with tumor cells; even three days or more after their initial exposure, they were still making CCL5. There's a two-way communication going on there."
